Ticker Details
Sutro Biopharma, Inc.
IPO Date:	October 12, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$443.34M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.29 | 3.46%
Avg Daily Range (30 D):	$0.63 | 2.76%
Avg Daily Range (90 D):	$0.58 | 4.08%

Institutional Daily Volume
Avg Daily Volume:	.42M
Avg Daily Volume (30 D):	.14M
Avg Daily Volume (90 D):	.16M

Trade Size
Avg Trade Size (Sh.):	117
Avg Trade Size (Sh.) (30 D):	52
Avg Trade Size (Sh.) (90 D):	58

Institutional Trades
Total Institutional Trades:	663
Avg Institutional Trade:	$1.61M
Avg Institutional Trade (30 D):	$1.49M
Avg Institutional Trade (90 D):	$1.31M
Avg Institutional Trade Volume:	.02M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.64M
Avg Closing Trade (30 D):	$2.26M
Avg Closing Trade (90 D):	$2M
Avg Closing Volume:	17.53K

News

Feb 10, 2026 @ 12:00 PM Sutro Biopharma Announces Pricing of $110.0 millio... Source: Na

Dec 3, 2025 @ 1:00 PM Sutro Biopharma Announces First Cohort of Patients... Source: Sutro Biopharma

Nov 12, 2025 @ 3:00 PM Sutro Biopharma Highlights Next-Generation ADC Inn... Source: Sutro Biopharma

Nov 3, 2025 @ 1:00 PM Sutro Biopharma Announces Participation at the 16t... Source: Sutro Biopharma

Aug 28, 2025 @ 2:44 PM FDA Tightens Survival Standards as Cancer Drug Pip... Source: Prnewswire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-22.49	$-20.78	$-22.49
Diluted EPS	$-22.49	$-20.78	$-22.49
Revenue	$102.48M	$11.65M	$102.48M
Gross Profit
Net Income / Loss	$-191.09M	$-46.76M	$-191.09M
Operating Income / Loss	$-158.37M	$-38.05M	$-158.37M
Cost of Revenue
Net Cash Flow	$-132.17M	$-7.8M	$-132.17M
PE Ratio

Splits
Dec 03, 2025	1:10